| 1. | | Recruiting | Hypnosis for Hot Flashes in Breast Cancer Survivors
Conditions: Breast Neoplasms; Hot Flashes; Menopause |
| 2. | | Recruiting | Exercise in Women at Risk for Breast Cancer
Condition: Breast Neoplasms |
| 3. | | Recruiting | Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
Condition: Breast Neoplasms |
| 4. | | Not yet recruiting | Weight Loss Counseling for African American Breast Cancer Survivors
Conditions: Obesity; Breast Neoplasms |
| 5. | | Recruiting | Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients
Conditions: Breast Neoplasms; Hot Flashes |
| 6. | | Recruiting | Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients
Conditions: Breast Neoplasms; Metastases |
| 7. | | Recruiting | Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors
Conditions: Breast Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Lung Neoplasms |
| 8. | | Recruiting | Stem Cell Transplant with Th2/Tc2 Cells to Treat Advanced Breast Cancer
Condition: Breast Neoplasms |
| 9. | | Recruiting | Sentinel Lymph Node Biopsy to Predict Cancer Spread to Axillary Lymph Nodes after Chemotherapy
Condition: Breast Neoplasms |
| 10. | | Recruiting | Influence of Garlic on Docetaxel Metabolism in Patients with Breast Cancer
Condition: Breast Neoplasms |
| 11. | | Recruiting | Inflammatory Breast Cancer and Tumor Markers
Condition: Breast Neoplasms |
| 12. | | Recruiting | A trial of exemestane alone or in combination with celecoxib in postmenopausal women with DCIS or at high risk for invasive breast cancer
Condition: Breast Neoplasms |
| 13. | | Recruiting | Comparison of Nolvadex 20 mg and placebo combination to Nolvadex 20 mg and ZD1839 (IRESSA™) 250 mg combination in patients with metastatic breast cancer and estrogen receptor (ER) and/or progesterone (PR) positive tumours
Condition: Breast Neoplasms |
| 14. | | Recruiting | Investigational Cancer Drug in Women with Metastatic Breast Cancer whose Cancer has Gotten Worse after Anthracycline and Taxane Therapy
Conditions: Breast Neoplasms; Neoplasm Metastasis |
| 15. | | Recruiting | FASLODEX and AROMASIN in Hormone Receptor Positive Postmenopausal Women with Advanced Breast Cancer
Conditions: Breast Neoplasms; Metastases, Neoplasm |
| 16. | | Recruiting | Therapy with docetaxel and ZD1839 for Patients who have advanced breast cancer
Condition: Breast Neoplasms |
| 17. | | Recruiting | Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer
Conditions: Breast Neoplasms; Metastases, Neoplasm |
| 18. | | Recruiting | Phase I/II Study of Tamoxifen and Tipifarnib to Treat Advanced Breast Cancer
Condition: Breast Neoplasms |
| 19. | | Recruiting | Phase III Study of Atamestane Plus Toremifene versus Letrozole in Advanced Breast Cancer
Conditions: Breast Neoplasms; Neoplasms, Hormone-Dependent |
| 20. | | Recruiting | Mistletoe Extract and Gemcitabine for the Treatment of Solid Tumor Cancers
Conditions: Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms |
| 21. | | Recruiting | Removal of the ovaries/fallopian tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Conditions: Ovarian Neoplasms; Breast Neoplasms |
| 22. | | Recruiting | Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Breast Neoplasms; Ovarian Neoplasms |
| 23. | | Recruiting | Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
Conditions: Breast Neoplasms; Breast Diseases; Metastases, Neoplasm |
| 24. | | Recruiting | Breast Duct Lavage and Breast Duct Endoscopy for Detecting Breast Cancer
Conditions: Breast Neoplasms; Healthy |
| 25. | | Recruiting | Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70
Condition: Breast Neoplasms |
| 26. | | Recruiting | Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
Condition: Breast Neoplasm |
| 27. | | Recruiting | Microarray Analysis for Human Genetic Disease
Conditions: Breast Neoplasm; Hereditary Neoplastic Syndrome; Melanoma; Ovarian Neoplasm |
| 28. | | Recruiting | p53 Peptide vaccination for Breast or Ovary Cancer
Conditions: Breast Cancer; Breast Neoplasm |
| 29. | | Recruiting | Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
Conditions: Breast Neoplasm; Neoplasm Metastasis |
| 30. | | Not yet recruiting | Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer; Male Breast Cancer |
| 31. | | Not yet recruiting | Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer; recurrent breast cancer; stage IV breast cancer |
| 32. | | Recruiting | Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; Male Breast Cancer; recurrent breast cancer |
| 33. | | Recruiting | In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
| 34. | | Recruiting | GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/neu
Conditions: stage IV breast cancer; Male Breast Cancer; recurrent breast cancer |
| 35. | | Recruiting | Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer |
| 36. | | Recruiting | Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
| 37. | | Recruiting | Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/neu-Positive Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
| 38. | | Recruiting | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; Male Breast Cancer; recurrent breast cancer |
| 39. | | Recruiting | Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer; Male Breast Cancer |
| 40. | | Recruiting | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer
Conditions: inflammatory breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; unspecified adult solid tumor, protocol specific |
| 41. | | Recruiting | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
Conditions: recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer |
| 42. | | Recruiting | GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
| 43. | | Recruiting | Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Conditions: stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer |
| 44. | | Recruiting | CP-724,714 in Treating Patients With Metastatic Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer; Male Breast Cancer |
| 45. | | Recruiting | Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
Conditions: Male Breast Cancer; recurrent breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer |
| 46. | | Recruiting | Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
| 47. | | Recruiting | Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Male Breast Cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer |
| 48. | | Recruiting | Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
| 49. | | Recruiting | Decitabine in Treating Patients With Advanced Solid Tumors
Conditions: adult solid tumor; Bladder Cancer; Breast Cancer; Male Breast Cancer; Melanoma |
| 50. | | Recruiting | Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
Conditions: stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer |
